UBS Group AG - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2023$1,139
-41.1%
619
-54.2%
0.00%
Q4 2022$1,935
+93.5%
1,353
+218.4%
0.00%
Q2 2022$1,0000.0%4250.0%0.00%
Q1 2022$1,000
-90.0%
425
-86.7%
0.00%
Q4 2021$10,000
-37.5%
3,204
-26.6%
0.00%
Q3 2021$16,000
+300.0%
4,364
+255.7%
0.00%
Q2 2021$4,000
-86.7%
1,227
-86.3%
0.00%
Q1 2021$30,000
-9.1%
8,933
-31.3%
0.00%
Q4 2020$33,000
+153.8%
13,008
+105.3%
0.00%
Q3 2020$13,000
-61.8%
6,335
-57.8%
0.00%
Q2 2020$34,000
-52.8%
14,995
-47.7%
0.00%
Q1 2020$72,000
-52.9%
28,652
-50.8%
0.00%
Q4 2019$153,000
-13.1%
58,229
+19.0%
0.00%
Q3 2019$176,000
+151.4%
48,938
+135.3%
0.00%
Q2 2019$70,000
+79.5%
20,798
+44.5%
0.00%
Q1 2019$39,000
-58.1%
14,390
-56.9%
0.00%
Q4 2018$93,000
-9.7%
33,382
+33.5%
0.00%
Q3 2018$103,000
-13.4%
25,013
+8.8%
0.00%
Q2 2018$119,000
+38.4%
22,999
+46.5%
0.00%
Q1 2018$86,000
-50.0%
15,696
-25.7%
0.00%
Q4 2017$172,000
-65.9%
21,119
-56.1%
0.00%
Q3 2017$504,000
-2.3%
48,099
+2.8%
0.00%
Q2 2017$516,000
+30.3%
46,777
-1.1%
0.00%
Q1 2017$396,000
+6.2%
47,315
-12.1%
0.00%
Q4 2016$373,000
+51.6%
53,837
+11.2%
0.00%
Q3 2016$246,000
-10.5%
48,401
+5.2%
0.00%
Q2 2016$275,000
-70.7%
46,010
-77.7%
0.00%
-100.0%
Q1 2016$940,000
+339.3%
206,535
+334.7%
0.00%
Q4 2015$214,000
+40.8%
47,510
-0.4%
0.00%
Q3 2015$152,000
-15.1%
47,717
-19.6%
0.00%
Q2 2015$179,000
+11.2%
59,359
+8.9%
0.00%
Q1 2015$161,000
+64.3%
54,510
+148.7%
0.00%
Q4 2014$98,00021,9190.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders